From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Navy Award to Eagle Applied Sciences for Biomedical Research

by Global Biodefense Staff
March 27, 2013

Naval Medical Research Unit - San Antonio (NAMRU-SA)The U.S. Navy has awarded a sole source bridge contract to Eagle Applied Sciences (EAS) for continued biomedical research and technical support to the Naval Medical Research Unit San Antonio (NAMRU-SA). 

EAS is currently performing support services for NAMRU-SA including efforts to evaluate biomedical products and new biomedical technologies to detect and prevent infectious diseases. EAS also performs a range of other clinical and nonclinical related research efforts for the military group such as: literature surveys, development of research hypotheses, experimental designs, and the collection and statistical analysis of research data.

The contract bridges services for two to five months while the government reconciles unforeseen delays in awarding a new competitive contract to EAS that was held up by overturned protests. Without the extension, NAMRU-SA states it would be seriously impacted in program efforts, specifically in clinical trial processes that require continuity.

The Naval Medical Research Unit San Antonio (NAMRU-SA) was established in May 2009 as the result of the Base Realignment and Closure (BRAC) 2005 Commission. As a result of the BRAC action, the Combat Casualty Care Department of the Naval Medical Research Center, the Institute for Dental and Biomedical Research as well as the Naval Health Research Center Command Directed Energy Bioeffects were realigned to Fort Sam Houston, Texas. 

As a result of these actions, a new command was established combining these missions into NAMRU-SA. Due to the reimbursable nature of NAMRU-SA’s research programs, the laboratory relies heavily on contractor support to ensure it achieves its mission.

The period of performance for the EAS contract is anticipated to be a base period of 2-months, from March 27, 2013 through May 31, 2013. The contract will also include three, 1-month option periods. Funding for the base and option periods is estimated at $284,900.90.

The Naval Medical Logistics Command (NMLC) is overseeing the action under Solicitation Number: N3239813NAMRU.

From Our Partners
Tags: Awards

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC